MedTrace Logo

Endoscopic Frontal Sinus Surgery Draf III in Moderate to Severe Eosinophilic Chronic Rhinosinusitis With Polyps

NCT05979662 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-08-07

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of the primary endoscopic frontal sinus surgery on the clinical outcome in patients having moderate to severe eosinophilic chronic rhinosinusitis with polyps with primary outcome measures in form of recurrence of polyp using endoscopic polyp score and Secondary outcome measures include Lund MacKay score, SNOT-22 and need for corticosteroid to control polyp postoperatively.

Conditions

Interventions

PROCEDURE

Endoscopic frontal sinus surgery grade 6(Draf III).

Patients will receive endoscopic frontal sinus surgery grade 6(Draf III).

PROCEDURE

Endoscopic frontal sinus surgery grade 1-3(Draf I or IIa)

Patients will receive endoscopic frontal sinus surgery grade 1-3(Draf I or IIa).

Sponsors & Collaborators

  • Ibrahim Talal Elshamy

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05979662 on ClinicalTrials.gov